Patents by Inventor Bruce F. Scharschmidt

Bruce F. Scharschmidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods of therapy for IGF-I-responsive conditions
    Publication number: 20030100505
    Abstract: Compositions and methods useful in therapy for IGF-I-responsive conditions in a mammal are provided. The method comprises concurrent therapy with both IGF-I or a variant thereof and at least one GAG to promote a desired therapeutic response with respect to a particular IGF-I-responsive condition. Concurrent therapy is achieved by administering to a mammal a single pharmaceutical composition containing both IGF-I (or a variant thereof) and at least one GAG according to a dosing regimen. Alternatively, IGF-I or a variant thereof and at least one GAG can be administered as two separate pharmaceutical compositions. A pharmaceutical composition comprising IGF-I or a variant thereof and at least one GAG for use in the IGF-I and GAG therapy is also provided.
    Type: Application
    Filed: October 24, 2002
    Publication date: May 29, 2003
    Applicant: Chiron Corporation
    Inventors: Bruce F. Scharschmidt, Alfredo Gorio, Eugenio E. Muller
  • Method for treating hepatitis B carriers with minimal disease
    Patent number: 5308833
    Abstract: Methods for treating minimal disease hepatitis B infection are disclosed. Minimal disease carriers are given thymosin .alpha.-1, or biologically active fragments or analogs thereof In this way, the indications of hepatitis B can be reduced or eliminated.
    Type: Grant
    Filed: February 6, 1992
    Date of Patent: May 3, 1994
    Assignee: SciClone Pharmaceuticals
    Inventors: Bruce F. Scharschmidt, John D. Baxter